Radiobiology and Radiotherapy Research Program

$21,169P30FY2013CANIH

Yale University, New Haven CT

Investigators

Linked publications, trials & patents

Paper 39677793 Paper 39528779 Paper 39386505 Paper 39326416 Paper 39240189 Paper 39190603 Paper 39108617 Paper 39102635 Paper 39037032 Paper 38986360 Paper 38969477 Paper 38964502 Paper 38924575 Paper 38916955 Paper 38837895 Paper 38770444 Paper 38752949 Paper 38740655 Paper 38736711 Paper 38625939 Paper 38594809 Paper 38579722 Paper 38547779 Paper 38514887 Paper 38470431 Paper 38464315 Paper 38400738 Paper 38378617 Paper 38359163 Paper 38251887 Paper 38165804 Paper 38076906 Paper 38060328 Paper 38060202 Paper 38042922 Paper 38012273 Paper 37977486 Paper 37964379 Paper 37959808 Paper 37873263 Paper 37835412 Paper 37756381 Paper 37742191 Paper 37729872 Paper 37669951 Paper 37648285 Paper 37646579 Paper 37634850 Paper 37577936 Paper 37568736 Paper 37566041 Paper 37546882 Paper 37541245 Paper 37541244 Paper 37526937 Paper 37487666 Paper 37459511 Paper 37444440 Paper 37410869 Paper 37391289 Paper 37385938 Paper 37384395 Paper 37382208 Paper 37286865 Paper 37286593 Paper 37269192 Paper 37246090 Paper 37240216 Paper 37200234 Paper 37187610 Paper 37092028 Paper 36925070 Paper 36894554 Paper 36889057 Paper 36881866 Paper 36865290 Paper 36803844 Paper 36788069 Paper 36775354 Paper 36775350 Paper 36739981 Paper 36712053 Paper 36610380 Paper 36550261 Paper 36525930 Paper 36520995 Paper 36493798 Paper 36473135 Paper 36449280 Paper 36442427 Paper 36302024 Paper 36301137 Trial NCT06572800 Trial NCT06169215 Trial NCT04848051 Trial NCT02319018 Trial NCT02314169 Trial NCT02047474 Trial NCT00576654 Trial NCT00436605

Abstract

PROJECT SUMMARY (See instructions): The program in Radiobiology & Radiotherapy (RR) comprises a broadly based, multifaceted research effort in radiation therapy, radiation biology, radiological physics and related areas of tumor biology. This program has been an approved component of the Yale Cancer Center Grant for over 25 years. Its long-term goal is to improve the treatment of cancer in general and in particular, the effectiveness of radiation therapy. The program includes a broad spectrum of activity that extends from laboratory-based experimental research to clinical investigation, and features investigators associated with 16 departments. Some of the key themes include studies of carcinogenesis, genetic instability and cell growth control; elucidation of DNA repair pathways; investigation of tumor hypoxia and development of hypoxia-targeted cancer therapies; molecular correlations with outcomes in radiation therapy; and improvements in radiation dosimetry, imaging, and delivery. The majority of RR members have rich interactions with the Yale Cancer

View original record on NIH RePORTER →